Investors
- VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE SUBMIT
- 2024-03-28
- VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR QUADRIVALENT INFLUENZA VIRUS VACCINE (MDCK CELLS) SUBMITTED
- 2024-03-28
- VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR NOVEL-PROCESS HIGHLY-EFFECTIVE HUMAN DIPLOID RABIES VACCINE SUBMITTED
- 2024-03-26
- NOTICE OF BOARD MEETING
- 2024-03-15
- VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR ABSORBED TETANUS VACCINE SUBMITTED
- 2024-03-04
- VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE II CLINICAL TRIAL OF TETRAVALENT MENINGOCOCCAL CONJUGATE VACCINE
- 2024-03-04
- PROFIT WARNING
- 2024-03-04
- VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE LAYOUT OF ITERATIVE RABIES VACCINE PRODUCTS AND FULLY ADVANCING THE RESEARCH AND DEVELOPMENT OF THE PRODUCT SERIES
- 2024-03-04
- VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE LAYOUT OF ITERATIVE PNEUMONIA VACCINE PRODUCTS AND FULLY ADVANCING THE RESEARCH AND DEVELOPMENT OF THE PRODUCT SERIES
- 2024-03-04
- VOLUNTARY ANNOUNCEMENT - EXPECTED COMPLETION OF APPLICATION FOR MARKETING OF 13-VALENT PNEUMONIA CONJUGATE VACCINE, ITERATIVE SERUM-FREE RABIES VACCINE AND 23-VALENT PNEUMONIA POLYSACCHARIDE VACCINE IN 2024
- 2024-03-04
- VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR MARKETING REGISTRATION FOR 13-VALENT PNEUMONIA CONJUGATE VACCINE SUBMITTED
- 2024-03-01
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
- 2024-03-01
- (1) POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON FEBRUARY 29, 2024; (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (3) APPOINTMENTS OF THE EXECUTIVE VICE-CHAIRMAN AND THE VICE-CHAIRMAN OF THE BOARD HAVING BECOME EFFECTIVE
- 2024-02-29
- (1) Notification Letter to Non-registered Shareholder and (2) Updated Arrangement of Electronic Dissemination of Corporate Communications
- 2024-02-08
- FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON FEBRUARY 29, 2024
- 2024-02-08
- PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
- 2024-02-08
- (1) ELECTION OF THE EXECUTIVE VICE-CHAIRMAN AND THE VICE-CHAIRMAN OF THE BOARD; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
- 2024-02-08
- CLOSURE OF REGISTER OF MEMBERS
- 2024-02-07
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
- 2024-02-01
- VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER
- 2024-01-10
- VOLUNTARY ANNOUNCEMENT - FURTHER CONTINUOUS INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER
- 2024-01-02
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
- 2024-01-02
- VOLUNTARY ANNOUNCEMENT - FURTHER CONTINUOUS INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER
- 2023-12-12
- VOLUNTARY ANNOUNCEMENT - FURTHER CONTINUOUS INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER
- 2023-12-06
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
- 2023-12-04
- VOLUNTARY ANNOUNCEMENT - FURTHER CONTINUOUS INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER
- 2023-11-30
- Articles of Association
- 2023-11-28
- (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING, THE DOMESTIC SHARE CLASS MEETING AND THE H SHARE CLASS MEETING HELD ON NOVEMBER 28, 2023; (2) ELECTION OF THE BOARD OF DIRECTORS IN THE SECOND SESSION; (3) ELECTION OF THE BOARD OF SUPERVISORS IN THE SECOND SESSION; (4) APPOINTMENT OF THE CHAIRMAN OF THE BOARD OF DIRECTORS AND THE BOARD OF SUPERVISORS IN THE SECOND SESSION; (5) CHANGE OF REGISTERED OFFICE; AND (6) AMENDMENTS TO THE ARTICLES OF ASSOCIATION
- 2023-11-28
- VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER
- 2023-11-21
- VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER
- 2023-11-17
- FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2023 THIRD H SHARE CLASS MEETING TO BE HELD ON NOVEMBER 28, 2023
- 2023-11-09
- FORM OF PROXY FOR HOLDERS OF H SHARES FOR THE 2023 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON NOVEMBER 28, 2023
- 2023-11-09
- NOTICE OF THE H SHARE CLASS MEETING
- 2023-11-09
- (1) PROPOSED RE-ELECTION OF DIRECTORS IN THE SECOND SESSION; (2) PROPOSED RE-ELECTION OF SHAREHOLDER REPRESENTATIVE SUPERVISORS IN THE SECOND SESSION; (3) PROPOSED CHANGE OF REGISTERED OFFICE; AND (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
- 2023-11-09
- CLOSURE OF REGISTER OF MEMBERS
- 2023-11-08
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
- 2023-11-03
- CHANGE IN USE OF IPO PROCEEDS
- 2023-10-23
- VOLUNTARY ANNOUNCEMENT - REGISTRATION APPLICATION FOR A SHARE LISTING TUTORING HAS BEEN FORMALLY ACCEPTED BY THE REGULATORY AUTHORITY
- 2023-10-17
- VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IS NEAR COMPLETION AND STATISTICAL UNBLINDING WILL COMMENCE SOON
- 2023-10-17
- VOLUNTARY ANNOUNCEMENT - SIGNING OF A SHARE LISTING TUTORING AGREEMENT AND FILING OF REGISTRATION APPLICATION FOR A SHARE LISTING TUTORING
- 2023-10-12
- INITIATION OF A SHARE LISTING PLAN
- 2023-10-08
- VOLUNTARY ANNOUNCEMENT - COMPLETION OF FULL COURSE OF VACCINATION IN SUBJECTS OF PHASE III CLINICAL TRIAL OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE
- 2023-10-08
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
- 2023-10-06
- VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF SERUM-FREE RABIES VACCINE ACHIEVED SATISFACTORY PHASE RESULTS
- 2023-09-20
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
- 2023-09-05
- (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
- 2023-09-05
- VOLUNTARY ANNOUNCEMENT - THE APPROVAL FOR THE ISSUANCE OF UNLISTED RMB DENOMINATED ORDINARY SHARES FROM THE CSRC
- 2023-08-30
- VOLUNTARY ANNOUNCEMENT - INITIATION OF RANDOMIZED, BLINDED AND COMPARABLE VACCINE-CONTROLLED PHASE III CLINICAL TRIAL OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE
- 2023-08-29
- 2023 INTERIM REPORT
- 2023-08-29
- NOTICE OF BOARD MEETING
- 2023-08-17
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
- 2023-08-01
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
- 2023-07-03
- VOLUNTARY ANNOUNCEMENT - BIVALENT mRNA VACCINE AGAINST COVID-19 VARIANTS DELTA AND OMICRON BA.5 OBTAINED CLINICAL TRIAL APPROVALS FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION
- 2023-06-29
- VOLUNTARY ANNOUNCEMENT - APPLICATION ACCEPTED FOR CLINICAL TRIAL OF HUMAN RABIES mRNA VACCINE AGAINST RABIES VIRUS
- 2023-06-12
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
- 2023-06-01
- VOLUNTARY ANNOUNCEMENT MAJOR RESULTS OF A DOMESTIC STUDY ON PROTECTIVE EFFICACY OF COVID-19 VARIANT OMICRON BA.5 mRNA VACCINE LVRNA012
- 2023-06-01
- POLL RESULTS OF THE ANNUAL GENERAL MEETING, THE 2023 SECOND CLASS MEETING FOR HOLDERS OF DOMESTIC SHARES AND THE 2023 SECOND H SHARE CLASS MEETING HELD ON MAY 28, 2023
- 2023-05-28
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
- 2023-05-04
- POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING, THE CLASS MEETING FOR HOLDERS OF DOMESTIC SHARES AND THE H SHARE CLASS MEETING HELD ON APRIL 28, 2023
- 2023-04-28
- FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2023 SECOND H SHARE CLASS MEETING TO BE HELD ON MAY 28, 2023
- 2023-04-21
- FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 28, 2023
- 2023-04-21
- NOTICE OF 2022 ANNUAL GENERAL MEETING
- 2023-04-21
- 2022 CIRCULAR OF ANNUAL GENERAL MEETING
- 2023-04-21
- FORM OF PROXY FOR HOLDERS OF H SHARES FOR THE 2023 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON APRIL 28, 2023
- 2023-04-11
- NOTICE OF H SHARE CLASS MEETING
- 2023-04-11
- NOTICE OF EXTRAORDINARY GENERAL MEETING
- 2023-04-11
- PROPOSED ISSUANCE OF UNLISTED RMB DENOMINATED ORDINARY SHARES UNDER SPECIFIC MANDATE, NOTICE OF THE EXTRAORDINARY GENERAL MEETING AND NOTICE OF THE H SHARE CLASS MEETING
- 2023-04-11
- CLOSURE OF REGISTER OF MEMBERS
- 2023-04-06
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
- 2023-04-03
- NOTICE OF BOARD MEETING
- 2023-03-17
- VOLUNTARY ANNOUNCEMENT - TETRAVALENT MENINGOCOCCAL CONJUGATE VACCINE CANDIDATE OFFICIALLY COMMENCED CLINICAL TRIAL
- 2023-03-17
- INSIDE INFORMATION-(1) PROPOSED ISSUANCE OF UNLISTED RMB DENOMINATED ORDINARY SHARES (2) PROPOSED AUTHORIZATIONS TO THE BOARD RELATING TO THE PROPOSED ISSUANCE (3) PROPOSED EGM AND CLASS MEETINGS
- 2023-03-08
- PROFIT WARNING
- 2023-03-03
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
- 2023-03-01
- VOLUNTARY ANNOUNCEMENT - MRNA COVID-19 VACCINE CANDIDATES AGAINST COVID-19 VARIANTS AND ORIGINAL STRAIN OBTAINED CLINICAL TRIAL APPROVALS IN PAKISTAN
- 2023-02-15
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
- 2023-02-06
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
- 2023-01-06
- (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
- 2023-01-06
- (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
- 2023-01-06
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
- 2022-12-01
- Next Day Disclosure Return
- 2022-11-02
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
- 2022-11-01